Douglas Kerr, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 4,425 shares at $13.27 ($59K) on 2025-09-04, disclosed to the SEC on 2025-09-08.
Scheduled sale ($59k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.27 | 3,552 | $47K | 80.1% |
| 2 | $13.41 | 873 | $12K | 19.9% |
| Total | $13.30 avg | 4,425 | $59K | 100% |
| Filing → |
| DYN | SELL | 2026-06-17 | $16K | — | Filing → |
| DYN | SELL | 2026-05-14 | $29K | — | Filing → |
| DYN | SELL | 2026-03-06 | $13K | — | Filing → |